Skip to content

Microbiome and Non-caloric Sweeteners in Humans

The Role of the Microbiome in Personalized Human Response to Non-caloric Sweeteners

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03708939
Enrollment
120
Registered
2018-10-17
Start date
2017-02-19
Completion date
2021-01-01
Last updated
2021-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Intolerance, Glucose, Low Blood, Glucose, High Blood

Brief summary

Non-caloric sweeteners are common food supplements consumed by millions worldwide as means of combating weight gain and diabetes, by retaining sweet taste without increasing caloric intake. While they are considered safe, there is increasing debate regarding their potential role in contributing to metabolic derangements in some humans. The investigators recently demonstrated that non-caloric sweeteners consumption could induce glucose intolerance in mice and, in preliminary experiments, in distinct human subsets, by functionally altering the gut microbiome, and that the gut microbiome plays an important role in mediating differential glucose responses to identical foods. The proportion of the human population that is susceptible to glucose intolerance induced by non-caloric sweeteners, the common factors that are shared between these individuals and whether and how the microbiome promotes the metabolic derangements remain to be addressed.

Interventions

DIETARY_SUPPLEMENTGlucose

Daily consumption of 5g of glucose, for 14 days.

DIETARY_SUPPLEMENTAspartame

Daily consumption of six commercially available sachets containing aspartame and glucose as bulking agent (1g each sachet), for 14 days.

DIETARY_SUPPLEMENTSucralose

Daily consumption of six commercially available sachets containing sucralose and glucose as bulking agent (1g each sachet), for 14 days.

DIETARY_SUPPLEMENTSaccharin

Daily consumption of six commercially available sachets containing saccharine and glucose as bulking agent (1g each sachet), for 14 days.

DIETARY_SUPPLEMENTStevia

Daily consumption of six commercially available sachets containing Stevia and glucose as bulking agent (1g each sachet), for 14 days.

Follow up without any dietary supplementation.

Sponsors

Weizmann Institute of Science
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. BMI\<28 2. Age - 18-70 3. Capable of working with smartphone application 4. Capable to work with a glucometer

Exclusion criteria

1. Consumption of antibitioics 3 months prior to the first day of the experiment. 2. Consumption of Non caloric sweetners 6 months prior to the first day of the experiment. 3. Diagnosis with type 1 or type 2 diabetes. 4. Pregnancy, fertility treatments 5. Breastfeeding (Including baby to breast and bottle feeding expressed breast milk) 6. Chronic disease (e.g. AIDS, Cushing syndrome, CKD, acromegaly, hyperthyroidism etc.) 7. Cancer and recent anticancer treatment 8. Psychiatric disorders 9. Coagulation disorders 10. IBD (inflammatory bowel diseases) 11. Bariatric surgery 12. Alcohol or substance abuse 13. BMI\>28 14. Aspartame group only: phenylketonuria.

Design outcomes

Primary

MeasureTime frameDescription
Blood glucose level28 daysContinuous glucose monitor device

Secondary

MeasureTime frameDescription
Microbiome28 daysStool and oral samples

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026